QUINACT Drug Patent Profile
✉ Email this page to a colleague
When do Quinact patents expire, and what generic alternatives are available?
Quinact is a drug marketed by Bayer Hlthcare and is included in two NDAs.
The generic ingredient in QUINACT is quinidine gluconate. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the quinidine gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Quinact
A generic version of QUINACT was approved as quinidine gluconate by SUN PHARM INDUSTRIES on February 11th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for QUINACT?
- What are the global sales for QUINACT?
- What is Average Wholesale Price for QUINACT?
Summary for QUINACT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Patent Applications: | 4,020 |
| DailyMed Link: | QUINACT at DailyMed |
US Patents and Regulatory Information for QUINACT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | QUINACT | quinidine gluconate | TABLET;ORAL | 085978-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Bayer Hlthcare | QUINACT | quinidine gluconate | TABLET;ORAL | 086099-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
